TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy

Tumor necrosis factor superfamily member 14 (LIGHT) has been in pre-clinical development for over a decade and shows promise as a modality of enhancing treatment approaches in the field of cancer immunotherapy. To date, LIGHT has been used to combat cancer in multiple tumor models where it can be co...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Immunol
Hlavní autoři: Skeate, Joseph G., Otsmaa, Mikk E., Prins, Ruben, Fernandez, Daniel J., Da Silva, Diane M., Kast, W. Martin
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7243824/
https://ncbi.nlm.nih.gov/pubmed/32499782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00922
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky